Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapy-Reference-Cited by-同舟云学术

Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapy

Published:2013-09 Issue:9 Volume:3 Page:e145-e145
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Qin L,Smith B D,Tsai H-L,Yaghi N K,Neela P H,Moake M,Fu J,Kasamon YL,Prince G T,Goswami M,Rosner G L,Levitsky H I,Hourigan C S^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/bcj201344.pdf

Reference60 articles.

1. Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE et al. Bone-marrow transplantation. N Engl J Med 1975; 292: 832–843.

2. Hourigan CS, Levitsky HI . Evaluation of current cancer immunotherapy: hemato-oncology. Cancer J (Sudbury, Mass.) 2011; 17: 309–324.

3. Rosenberg SA . Raising the bar: the curative potential of human cancer immunotherapy. Sci Transl Med 2012; 4: 127ps8.

4. Porter DL, Levine BL, Kalos M, Bagg A, June CH . Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med 2011; 365: 725–733.

5. Heslop HE, Slobod KS, Pule MA, Hale GA, Rousseau A, Smith CA et al. Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood 2010; 115: 925–935.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influenza Virus Inactivated by Heavy Ion Beam Irradiation Stimulates Antigen-Specific Immune Responses;Pharmaceutics;2024-03-27

2. Generation of whole tumor cell vaccine for on-demand manipulation of immune responses against cancer under near-infrared laser irradiation;Nature Communications;2023-07-26

3. Characterization of CAR T Cells Manufactured using Genetically Engineered Artificial Antigen Presenting Cells;2023-06-30

4. A randomized, phase II trial of adjuvant immunotherapy with durable TKI-free survival in patients with chronic phase CML;Leukemia Research;2021-12

5. Side Effects and Sequelae of Treatment for Chronic Myeloid Leukemia in Childhood and Adolescence;Late Treatment Effects and Cancer Survivor Care in the Young;2020-11-06